In a candid interview at Davos, California Governor Gavin Newsom speculated that market instability could lead President Trump to soften his aggressive stance on Greenland. Newsom emphasized the impact of economic factors on Trump's decisions, highlighting the tension between U.S. and European relations.
In a heated moment at a Ford factory, President Trump responded to a heckler with an offensive gesture, leading to backlash and a suspension for the heckler. The White House defended Trump's reaction amid ongoing scrutiny of his ties to Jeffrey Epstein.
In a stunning turn of events, the FBI executed a search warrant at a Washington Post reporter’s residence, linked to an investigation of a government contractor accused of mishandling classified materials.
During a visit to a Ford factory in Michigan, President Trump raised his middle finger at a heckler accusing him of being a 'pedophile protector.' The moment was captured on video and shared by TMZ, sparking widespread attention.
In a surprising moment during a Ford plant tour, President Trump was caught on camera making an obscene gesture towards a heckler, a move the White House defended as 'appropriate.' This incident has sparked widespread discussion.
In a sweeping executive order, President Trump mandates major changes in defense contracting to prioritize military readiness over profits, halting stock buybacks and dividends for underperforming firms.
A devastating fire at the Wang Fuk Court housing estate in Hong Kong has claimed over 150 lives. Investigators uncover a scandal involving substandard scaffolding materials that were concealed from inspectors.
In her new podcast, Allison Mack reflects on her involvement with NXIVM and how she used her fame to manipulate others. From her role in the cult to her journey of redemption, Mack shares her story like never before.
Apple is reportedly working on a second-generation iPhone Air, potentially featuring dual cameras. This stunning device may redefine smartphone design, making it a must-have for enthusiasts.
Two biotech companies are developing groundbreaking gene therapies that could lead to a single injection for weight loss and blood sugar control. Initial tests show promising results in mice, with human trials on the horizon.